Voyager Therapeutics, Inc. Common Stock (NASDAQ: VYGR) last traded at $3.39, up 2.11% on the session. The quote above updates while this page is open; the figures below are drawn from Voyager Therapeutics, Inc. Common Stock’s own filings and are restated only when a new one is published.
Voyager Therapeutics, Inc. Common Stock trades on NASDAQ under the ticker VYGR. Its market capitalisation is $208.88 million.
Valuation measures for Voyager Therapeutics, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $208.88M |
|---|---|
| Enterprise value | $216.49M |
| Price / sales | 6.06 |
| Price / book | 1.35 |
| Beta | 1.33 |
Trailing-twelve-month figures tagged in Voyager Therapeutics, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $34.46M |
|---|---|
| Net income (TTM) | -$107.73M |
| EPS (TTM) | -$1.81 |
| Operating margin | -340.08% |
| Return on equity | -69.78% |
| Cash | $35.77M |
Range and volume for VYGR over the past 52 weeks.
| 52-week high | $5.55 |
|---|---|
| 52-week low | $2.94 |
| Volume | 415.9K |
| Average volume | 607.6K |
| Previous close | $3.32 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.